SOLACE2 is a phase II national clinical trial investigating whether immunological priming could improve the subsequent response to immunotherapy in women with the most common type of ovarian cancer (high-grade serous) at the first sign of [...]
ANZGOG member and Mercy Health's Professor Peter Grant has been recognised with a Medal of the Order of Australia in the General Division (OAM) for his service to gynaecological oncology. Professor Peter Grant OAM [...]
Elsa Larsen lost her sister Kristen to ovarian cancer, after battling the disease for 6 years. Elsa was invited to share Kristen's story at the 2021 Cancer Nurses Society of Australia (CNSA) Annual Congress. [...]
A new journal has been published by the Journal for ImmunoTherapy of Cancer for ANZGOG's PHAEDRA study. The PHAEDRA study examined the activity of the immunotherapeutic agent durvalumab in women with advanced endometrial cancer that [...]
A significant international study in cervical cancer treatment, the ANZGOG-led OUTBACK trial will be presented at the 2021 ASCO Annual Meeting Plenary Session to reveal its highly anticipated results. OUTBACK is an academic collaboration [...]
In light of International Nurses Day that marks the contribution that nurses make to society, meet Victoria, regional nurse and ovarian cancer survivor. Victoria's story demonstrates the impact of her diagnosis, the importance of gynaecological nurses, [...]
Shannon Philp, one of Australia’s first nurse practitioners in gynae-oncology, has received the 2021 HESTA Nurse of the Year award. The award recgonises and celebrates Shannon’s contribution to nursing education and patient-centred care for women, as [...]
In recent news, the American Society of Clinical Oncology (ASCO) has selected OUTBACK, an ANZGOG cervical cancer study, to be presented during the Plenary Session at their upcoming 2021 Annual Meeting. OUTBACK is an international trial [...]
ANGOG's 2022 ASM Steering Committee has experienced changes to its members, as Dr Paul Cohen has taken on a new role. The recent committee changes at ANZGOG have taken place in the 2022 ASM Steering [...]
On April 30th the Gynecological Cancer InterGroup’s (GCIG) Spring Meeting commences, where participants from various international gynaecologic cancer research groups will discuss the latest developments in gynaecologic cancer clinical trials. Assoc Prof Alison Brand AM [...]
Australia New Zealand Gynaecological Oncology Group www.anzgog.org.au
Level 6, Lifehouse, 119-143 Missenden Road Camperdown NSW 2050 T:+61 2 8071 4880
E: contact@anzgog.org.au © 2025 ANZGOG | Copyright | Disclaimer | ANZGOG Policies | Whistleblower
Virtually every advance in cancer survival has been made on the back of clinical trials.
As the peak, national gynaecological cancer clinical trials organisation for Australia and New Zealand, ANZGOG‘s purpose is to improve outcomes and quality of life for women with gynaecological cancer by conducting research.
We conduct and promote clinical trials and undertake multidisciplinary research into the causes, prevention and treatments of gynaecological cancers.
Research Community Volunteers will have the opportunity to contribute to ANZGOG research at every stage of the development process.
Community volunteers will lend their voices to research discussions sharing their personal perspective and representing the broader views of people with lived experience of gynaecological cancer.
Opportunities range from sharing your lived experience as a participant on a research grant working party or a Trial Management Committee, through to Research Advisor and Expert roles requiring additional levels of education and expertise in research analysis.
Gynaecological cancer research is critically needed but critically underfunded. WomenCan is the fundraising arm of ANZGOG, supporting ANZGOG by funding our programs to improve life for women with gynaecological cancer.
WomenCan’s mission is to engage the community to fund pioneering discoveries that will enable women with a gynaecological cancer to live better and live longer.
WomenCan believes the power of the collective, united in a common purpose, can make a real difference in the lives of women with gynaecological cancers.
ANZGOG’s Survivors Teaching Students (STS) Program is a ground-breaking volunteer program that brings gynaecological cancer survivors and caregivers into the classrooms of health professional students to teach them about women’s experiences with the diseases.
Survivors and caregivers are in a unique position to help students understand the ‘lived experience’ of a gynaecological cancer, including the psychosocial impact, and the importance of timely diagnosis, good health communication and compassionate care.
By joining STS and sharing your story, you will have the opportunity to impact the future care of women diagnosed with a gynaecological cancer, with participating students reporting not only increased understanding of gynaecological cancers but also a deeper understanding of the patient experience to take forward into their practice.
Since the program began at ANZGOG in 2017, our volunteers have shared their stories with more than 11,000 students across Australia and New Zealand.
